Your Health, We Care
selpercatinib, as a targeted drug targeting the RET gene, has shown significant efficacy in treating RET fusion positive metastatic non-small cell lung cancer and medullary thyroid carcinoma. However, as a medication, it may also cause some adverse reactions, and patients should pay close attention and follow the doctor's advice during use.
Selpercatinib is a targeted therapy drug that is specifically used for cancers associated with the RET gene. It reduces the spread of cancer cells by inhibiting RET kinase. It is s···【more】
Article source：Lucius LaosRelease date：2024-08-15Recommended：124
As a highly selective RET inhibitor, Selpercatinib can effectively block the RET signaling pathway. It is primarily used for the treatment of RET fusion-positive solid tumors. Pati···【more】
Article source：Lucius LaosRelease date：2024-08-15Recommended：157
Selpercatinib is a targeted drug for the treatment of RET gene mutations, which was approved by the FDA in May 2020 for the treatment of cancer patients with abnormal RET kinase mu···【more】
Article source：Lucius LaosRelease date：2024-08-14Recommended：135
Lucius Pharmaceuticals (Lao) LTD. (Lucius Pharmaceuticals), with its manufacturing campus in Laos located in the capital city of Vientiane in 2020, officially begins its great journey to make effective and affordable medicines available to people in need around the world...More
Lucius Pharmaceutical Co., Ltd., was established in 2020 in Vientiane, the capital of Laos. It aims to offer safe, effective, and affordable medicines globally. With a factory spanning 25,000 square meters, the company manufactures 200+ generic drugs in diverse therapeutic fields.
Address:No.26 Thongmang village, Xaythany district, Vientiane Capital, Laos
E-mail:laoslucius@gmail.com
Whatsapp:
